Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers-Reference-Cited by-同舟云学术

Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers

Published:2023-09 Issue: Volume:382 Page:578164
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Adamec Ivan,Brecl Jakob Gregor,Rajda Cecilia,Drulović Jelena,Radulović Ljiljana,Bašić Kes Vanja,Lazibat Ines,Rimac Julija,Cindrić Igor,Gržinčić Tihana,Abičić Ana,Barun Barbara,Gabelić Tereza,Gomezelj Sarah,Mesaroš Šarlota,Pekmezović Tatjana,Klivényi Péter,Krbot Skorić Magdalena,Habek Mario

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference24 articles.

1. Potential mechanisms of action related to the efficacy and safety of cladribine;Baker;Mult. Scler. Relat. Disord.,2019

2. A real-world single-Centre analysis of alemtuzumab and cladribine for multiple sclerosis;Bose;Mult. Scler. Relat. Disord.,2021

3. Reactivation of hepatitis B virus with immune-escape mutations after Ocrelizumab treatment for multiple sclerosis;Ciardi;Open Forum. Infect. Dis.,2018

4. Safety of cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis;Cook;Mult. Scler. Relat. Disord.,2019

5. Cladribine tablets: a review in relapsing MS;Deeks;CNS Drugs,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France;Neurology and Therapy;2024-03-15